Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Peritonitis D010538 38 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Spasm D013035 5 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Thalassemia D013789 8 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Thomet OA et al. Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus. 2001 Biochem. Pharmacol. pmid:11286996
Hayashi J et al. Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats. 2001 Nephron pmid:11287764
Choi JH et al. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. 2001 J. Immunol. pmid:11290796
Marathe GK et al. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. 2001 J. Lipid Res. pmid:11290831
Min JH et al. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme. 2001 Biochemistry pmid:11294621
Richardson RM et al. RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses. 2001 Biochemistry pmid:11297424
Kuijpers TW et al. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. 2001 Clin. Exp. Immunol. pmid:11298128
Teeling JL et al. Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model. 2001 Br. J. Haematol. pmid:11298603
Teather LA et al. Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. 2001 Neurobiol Learn Mem pmid:11300737
Aiboshi J et al. Blood transfusion and the two-insult model of post-injury multiple organ failure. 2001 Shock pmid:11303730
Ilveskero S et al. Procoagulant activity on platelets adhered to collagen or plasma clot. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11304482
Ishizuka S et al. Acid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expression. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11306440
Dery RE et al. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). 2001 Jan-Mar Int. Arch. Allergy Immunol. pmid:11306968
Lukashova V et al. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor. 2001 J. Biol. Chem. pmid:11309383
Grassi S and Pettorossi VE Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. 2001 Prog. Neurobiol. pmid:11311461
Panayiotou A et al. Lipid fractions with aggregatory and antiaggregatory activity toward platelets in fresh and fried cod (Gadus morhua): correlation with platelet-activating factor and atherogenesis. 2000 J. Agric. Food Chem. pmid:11312810
Yildirim G et al. Does the platelet-activating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. 2000 Biol Trace Elem Res pmid:11318001
Yan GT et al. [Effect of calcium overload and platelet activating factor on calcitonin gene related peptide release from lung tissue]. 1998 Sheng Li Xue Bao pmid:11324524
Alam N et al. Additional bioactive Lyso-PAF congeners from the sponge Spirastrella abata. 2001 J. Nat. Prod. pmid:11325244
Kato M et al. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis. 2001 J Ocul Pharmacol Ther pmid:11327052
Caplan MS et al. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. 2001 Pediatr. Res. pmid:11328947
Sugano T et al. Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts. 2001 Mol. Hum. Reprod. pmid:11331671
Taylor KE et al. Could platelet activating factor play a role in developmental dyslexia? 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11334553
Vittimberga FJ et al. Endotoxin fails to stimulate inositol triphosphate production in macrophages. 1999 Int. J. Surg. Investig. pmid:11341611
Hattar K et al. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors. 2001 J. Immunol. pmid:11342652
Marcano H et al. Effect of dopamine on platelet activating factor induced-pulmonary edema in isolated and perfused rabbit lungs. 2001 Respir Physiol pmid:11348642
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157
Wu C et al. Evidence for the autocrine induction of capacitation of mammalian spermatozoa. 2001 J. Biol. Chem. pmid:11350972
Taylor R et al. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction. 2001 Clin. Sci. pmid:11352774
Ferland C et al. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. 2001 J. Leukoc. Biol. pmid:11358986
Lee T et al. Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. 2001 Arch. Biochem. Biophys. pmid:11368182
Tu W et al. [Influences of BN50739 on neutrophil elastase and phospholipase A2 in lung and tracheal mucosa of pigs with acute severe pancreatitis]. 2000 Zhonghua Jie He He Hu Xi Za Zhi pmid:11372382
Iwase M et al. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. 2001 Crit. Care Med. pmid:11373429
Rosa MS et al. Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis. 2001 Curr. Microbiol. pmid:11375661
Hirashima Y et al. Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety. 2001 Neurol. Med. Chir. (Tokyo) pmid:11381675
Liu XH et al. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. 2001 Pediatr. Res. pmid:11385142
Mi B and Maleczka RE A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. 2001 Org. Lett. pmid:11388849
Roudebush WE and Diehl JR Platelet-activating factor content in boar spermatozoa correlates with fertility. 2001 Theriogenology pmid:11396471
Elzi DJ et al. Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. 2001 Am. J. Physiol., Cell Physiol. pmid:11401859
Tiemann U et al. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. 2001 Prostaglandins Other Lipid Mediat. pmid:11403499
Tong N et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. 2001 Eur. J. Neurosci. pmid:11403684
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Burke JR et al. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. 2001 J. Pharmacol. Exp. Ther. pmid:11408565
Briton-Jones C et al. The effects of follicular fluid and platelet-activating factor on motion characteristics of poor-quality cryopreserved human sperm. 2001 J. Assist. Reprod. Genet. pmid:11411433
Mizuno S et al. Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. 2001 Dig. Dis. Sci. pmid:11414308
Jehle R et al. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. 2001 Biochim. Biophys. Acta pmid:11420174
Kulikov VI and Muzya GI Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. 2001 Biochemistry Mosc. pmid:11421815
Virchow JC et al. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. 2001 Clin. Exp. Allergy pmid:11422147
Wang H et al. Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. 2001 Br. J. Pharmacol. pmid:11429396
Tsoukatos DC et al. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. 2001 Biochem. J. pmid:11439095
Miguel BG et al. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. 2001 Prostaglandins Other Lipid Mediat. pmid:11444588
Thom SR et al. Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. 2001 Am. J. Physiol. Heart Circ. Physiol. pmid:11454599
Grosman N Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. 2001 Int. Immunopharmacol. pmid:11460312
Raggers RJ et al. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. 2001 Biochem. J. pmid:11463358
Hollmann MW et al. Local anesthetic effects on priming and activation of human neutrophils. 2001 Anesthesiology pmid:11465548
Lane JS et al. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. 2001 J. Surg. Res. pmid:11469912
Velasquez LA et al. PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus. 2001 Hum. Reprod. pmid:11473946
Akisu M et al. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. 2001 Eur J Pediatr Surg pmid:11475112
Zhang J et al. [Experimental study on effect of Buyang Huanwu decoction on arterial blood platelet activating factor content pre- and post-arterial thrombosis of rats]. 1998 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11475720
Chang PY et al. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. 2001 Circulation pmid:11479258
Hermoso M et al. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. 2001 Pflugers Arch. pmid:11484763
Sachais BS Platelet-endothelial interactions in atherosclerosis. 2001 Curr Atheroscler Rep pmid:11487452
Jantan I et al. Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. 2001 Planta Med. pmid:11488464
Coker A et al. Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? 2001 Jul-Aug Hepatogastroenterology pmid:11490817
Hu LH et al. Synthesis and biological activity of amide derivatives of ginkgolide A. 2001 J Asian Nat Prod Res pmid:11491398
Alvarez A and Sanz MJ Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. 2001 J. Leukoc. Biol. pmid:11493611
Liu Y et al. [The role and significance of PAF in the early pulmonary injury following burns combined with endotoxemia in rats]. 1999 Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi pmid:11501075
Hourton D et al. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity. 2001 Eur. J. Biochem. pmid:11502209
Stoddart NR et al. Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects. 2001 Zygote pmid:11510473
Feldman C et al. Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro. 2001 Eur. Respir. J. pmid:11510782
Mooren FC et al. Decoupling of intracellular calcium signaling in granulocytes after exhaustive exercise. 2001 Int J Sports Med pmid:11510867
Marathe GK et al. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. 2001 J. Lipid Res. pmid:11518762
Smith DG et al. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. 2001 J. Neurovirol. pmid:11519483
Hoenstein R et al. Interleukin-2 activates human peripheral blood eosinophils. 2001 Cell. Immunol. pmid:11520078
Carceller E et al. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. 2001 J. Med. Chem. pmid:11520209
Dubois MJ and Vincent JL Clinically-oriented therapies in sepsis: a review. 2000 J. Endotoxin Res. pmid:11521072
Bernatchez PN et al. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. 2001 Br. J. Pharmacol. pmid:11522612
Emingil G et al. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. 2001 J. Periodontol. pmid:11525434
McManus LM et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. 2001 J. Leukoc. Biol. pmid:11527989
Qian C et al. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. 2001 Pharmacol. Res. pmid:11529688
Thomet OA et al. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. 2001 Clin. Exp. Allergy pmid:11529903
Watanabe S et al. Suppression of platelet-activating factor generation and modulation of arachidonate metabolism by dietary enrichment with (n-9) eicosatrienoic acid or docosahexaenoic acid in mouse peritoneal cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11534547
Stafforini DM PAF acetylhydrolase gene polymorphisms and asthma severity. 2001 Pharmacogenomics pmid:11535107
Steer ML Relationship between pancreatitis and lung diseases. 2001 Respir Physiol pmid:11535257
Fazal N et al. PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo. 2001 Am. J. Physiol., Cell Physiol. pmid:11546669
Tokutomi T et al. Production of platelet-activating factor by neuronal cells in the rat brain with cold injury. 2001 Neurol. Res. pmid:11547929
Denizot Y et al. Is there a role of platelet-activating factor in human lung cancer? 2001 Aug-Sep Lung Cancer pmid:11551414
Chemler SR et al. Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. 2001 Org. Lett. pmid:11554815
Kavakli K et al. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease. 2001 Haemophilia pmid:11554936
Rozenfeld RA et al. Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557516
Fukunaga K et al. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. 2001 J. Biol. Chem. pmid:11560941
Tsai JJ and Wang TF Different densities of human eosinophils respond differently to PAF and IL-5. 1999 J Microbiol Immunol Infect pmid:11561566
Zhao L et al. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. 2001 Br. J. Pharmacol. pmid:11564653
McKenna DJ et al. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. 2001 Sep-Oct Altern Ther Health Med pmid:11565403
Bhatia M et al. Inflammatory mediators as therapeutic targets in acute pancreatitis. 2001 Curr Opin Investig Drugs pmid:11566005
Khoo C et al. Inhibition of store-operated Ca(2+) influx by acidic extracellular pH in cultured human microglia. 2001 Glia pmid:11571781
Mariano F et al. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. 2001 Kidney Int. pmid:11576379
Christie PE and Henderson WR Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. 2002 Clin Allergy Immunol pmid:11577541
Jolly S et al. Effect of intravenous platelet-activating factor on bovine pulmonary mast cells. 2001 Aug-Oct J. Comp. Pathol. pmid:11578122
Sirolli V et al. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. 2001 Thromb. Haemost. pmid:11583316